Bioanalytical Systems (BASI) Posts Q4 GAAP Loss of 32c/Share

Bioanalytical Systems (NASDAQ: BASI) reported Q4 EPS of ($0.32), which may not compare with the analyst estimate of ($0.03). Revenue for the quarter came in at $6.54 million versus the consensus estimate of $7.07 million.

EBITDAR, a non-GAAP measure, improved from $205,000 last year to $891,000 in the recent quarter.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Cummins wins battery storage contract for U.S. data center project
• Raymond James sees positive earnings trends across market caps